Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 63, Issue 6, Pages 1796-1808
Publisher
Wiley
Online
2016-02-11
DOI
10.1002/hep.28497
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatment
- (2016) Nik Howes et al. Open Forum Infectious Diseases
- Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons
- (2015) Tianhua He et al. ANNALS OF INTERNAL MEDICINE
- Hepatitis C Virus Therapeutic Development: In Pursuit of "Perfectovir"
- (2015) G. J. Dore et al. CLINICAL INFECTIOUS DISEASES
- Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis
- (2015) Eric Lawitz et al. HEPATOLOGY
- A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs
- (2015) T Spelman et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis
- (2015) E. L. Haseltine et al. JOURNAL OF VIRAL HEPATITIS
- A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons
- (2014) N. Craine et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?
- (2014) Hamish Innes et al. GUT
- Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
- (2014) D Hartwell et al. HEALTH TECHNOLOGY ASSESSMENT
- An audit of hepatitis C service provision in a representative sample of prisons in England
- (2014) C. Humphreys et al. JOURNAL OF PUBLIC HEALTH
- HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact
- (2014) N. K. Martin et al. JOURNAL OF VIRAL HEPATITIS
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
- (2013) Rebecca L. Morgan et al. ANNALS OF INTERNAL MEDICINE
- Sustained Drug Use Changes After Hepatitis C Screening and Counseling Among Recently Infected Persons Who Inject Drugs: A Longitudinal Study
- (2013) J. Bruneau et al. CLINICAL INFECTIOUS DISEASES
- Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis
- (2013) Sarah Larney et al. HEPATOLOGY
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C
- (2013) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
- (2013) Natasha K Martin et al. BMJ Open
- Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland
- (2012) Scott A. McDonald et al. JOURNAL OF HEPATOLOGY
- Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis
- (2011) Ross J. Harris et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
- (2011) Natasha K. Martin et al. HEPATOLOGY
- Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
- (2009) Savino Bruno et al. HEPATOLOGY
- Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
- (2008) Hla-Hla Thein et al. HEPATOLOGY
- An evidence synthesis approach to estimating Hepatitis C Prevalence in England and Wales
- (2008) D. De Angelis et al. STATISTICAL METHODS IN MEDICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started